Paul Tudor Jones's ELV Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 77.7K shares of Elevance Health, Inc. (ELV) worth $25.1 M, representing 0.04% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in ELV, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2015, adding 135.9K shares. Largest reduction occurred in Q2 2015, reducing 130.5K shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +20,964 | New Buy | 20,964 | $125.69 |
| Q1 2015 | +135,936 | Add 648.43% | 156,900 | $154.41 |
| Q2 2015 | -130,543 | Reduce 83.20% | 26,357 | $164.13 |
| Q3 2015 | -12,190 | Reduce 46.25% | 14,167 | $139.97 |
| Q4 2015 | -9,767 | Reduce 68.94% | 4,400 | $139.55 |
| Q1 2016 | -2,000 | Reduce 45.45% | 2,400 | $139.17 |
| Q2 2016 | +12,854 | Add 535.58% | 15,254 | $131.31 |
| Q3 2016 | -15,254 | Sold Out | 15,254 | $0.00 |
| Q4 2016 | +4,800 | New Buy | 4,800 | $143.75 |
| Q1 2017 | -2,200 | Reduce 45.83% | 2,600 | $165.38 |
| Q2 2017 | +9,798 | Add 376.85% | 12,398 | $188.09 |
| Q3 2017 | -1,261 | Reduce 10.17% | 11,137 | $189.91 |
| Q4 2017 | +767 | Add 6.89% | 11,904 | $225.05 |
| Q1 2018 | -11,904 | Sold Out | 11,904 | $0.00 |
| Q1 2019 | +9,151 | New Buy | 9,151 | $286.96 |
| Q2 2019 | -9,151 | Sold Out | 9,151 | $0.00 |
| Q3 2019 | +46,768 | New Buy | 46,768 | $240.10 |
| Q4 2019 | -32,844 | Reduce 70.23% | 13,924 | $302.00 |
| Q1 2020 | -5,010 | Reduce 35.98% | 8,914 | $227.06 |
| Q2 2020 | +5,659 | Add 63.48% | 14,573 | $262.95 |
| Q3 2020 | -1,878 | Reduce 12.89% | 12,695 | $268.61 |
| Q4 2020 | -6,109 | Reduce 48.12% | 6,586 | $321.14 |
| Q1 2021 | -6,586 | Sold Out | 6,586 | $0.00 |
| Q2 2021 | +10,852 | New Buy | 10,852 | $381.77 |
| Q3 2021 | -7,584 | Reduce 69.89% | 3,268 | $372.71 |
| Q4 2021 | -3,268 | Sold Out | 3,268 | $0.00 |
| Q1 2022 | +3,497 | New Buy | 3,497 | $491.28 |
| Q2 2022 | +24,356 | Add 696.48% | 27,853 | $482.57 |
| Q3 2022 | +13,515 | Add 48.52% | 41,368 | $454.24 |
| Q4 2022 | -41,368 | Sold Out | 41,368 | $0.00 |
| Q1 2023 | +4,002 | New Buy | 4,002 | $0.46 |
| Q2 2023 | +11,368 | Add 284.06% | 15,370 | $444.29 |
| Q3 2023 | -12,376 | Reduce 80.52% | 2,994 | $435.42 |
| Q4 2023 | -2,994 | Sold Out | 2,994 | $0.00 |
| Q3 2024 | +41,178 | New Buy | 41,178 | $520.00 |
| Q4 2024 | -4,129 | Reduce 10.03% | 37,049 | $368.90 |
| Q1 2025 | -37,049 | Sold Out | 37,049 | $0.00 |
| Q3 2025 | +77,687 | New Buy | 77,687 | $323.12 |
Paul Tudor Jones's Elevance Health Investment FAQs
Paul Tudor Jones first purchased Elevance Health, Inc. (ELV) in Q4 2014, acquiring 20,964 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Elevance Health, Inc. (ELV) for 44 quarters since Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Elevance Health, Inc. (ELV) was in Q1 2015, adding 156,900 shares worth $24.23 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 77,687 shares of Elevance Health, Inc. (ELV), valued at approximately $25.1 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Elevance Health, Inc. (ELV) represents approximately 0.04% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Elevance Health, Inc. (ELV) was 156,900 shares, as reported at the end of Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.